Then, we combined SA-GM-CSF-anchored vaccine treatment with blockade of PD-1 and Tim-3 in an established subcutaneous bladder cancer model and found that this combination therapy significantly suppressed tumor growth, and tumor regression was increased in over 50% of the mice. This evidence concerns the gene CSF2 and urinary bladder cancer.